Form 4: Generation Bio Co. Director Acquires 60,000 Stock Options
SEC Form 4 Filing
Charles A. Rowland Jr., a director of Generation Bio Co., acquired 60,000 stock options on June 6, 2024, at an exercise price of $3.32.
Summary
- On June 6, 2024, Charles A. Rowland Jr., a director of Generation Bio Co., acquired 60,000 stock options.
- The exercise price for these options is $3.32.
- The options vest fully on the earlier of June 6, 2025, or the date of Generation Bio's 2025 annual meeting of stockholders.
- The options expire on June 5, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, indicating a neutral sentiment.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders, aligning management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of transaction: Charles A. Rowland Jr. acquired 60,000 stock options. |
| 06/06/2025 | Earliest vesting date for the stock options. |
| 06/05/2034 | Expiration date of the stock options. |
| 06/10/2024 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.